Crystal financial tombstone celebrating Series B financing for Nuvig Therapeutics. The immune drug developer is based in Menlo Park, California. (24ALJ345)
Crystal financial tombstone celebrating Series B financing for Nuvig Therapeutics. The immune drug developer is based in Menlo Park, California. (24ALJ345)
Side view of laboratory bottle-themed deal tombstone marking a Series B investment in immunology start-up Nuvig Therapeutics. The biopharma company will use the funds to develop antibody drugs for the treatment of autoimmune conditions.